Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2004
06/08/2004US6746989 Substituted benzoylpyrazoles as herbicides
06/08/2004CA2307552C Substituted pyridine compounds as anti-inflammatory agents
06/03/2004WO2004046141A1 New tricyclic angiotensin ii agonists
06/03/2004WO2004046139A1 Benzofuran derivates, process for their preparation and intermediates thereof
06/03/2004WO2004046138A1 Carboxamides
06/03/2004WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors
06/03/2004WO2004046124A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
06/03/2004WO2004046123A1 Benzoxazole, benzthiazole and benzimidazole derivatives useful as heparanase inhibitors
06/03/2004WO2004046122A2 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
06/03/2004WO2004046120A2 Diaminotriazoles useful as inhibitors of protein kinases
06/03/2004WO2004046119A1 Substituted aralkyl derivatives
06/03/2004WO2004046118A2 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
06/03/2004WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors
06/03/2004WO2004046103A2 Arylpyridine compounds
06/03/2004WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication
06/03/2004WO2004046092A2 Aryl sulfonamides
06/03/2004WO2004045616A1 N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
06/03/2004WO2004045392A2 Diagnostic method for celiac sprue
06/03/2004WO2004022060A8 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
06/03/2004WO2004018419A3 Benzimidazole quinolinones and uses thereof
06/03/2004WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106833 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
06/03/2004US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
06/03/2004US20040106793 treating asthma, adult respiratory distress syndrome, stroke, bone reasorption diseases, arthritic joint conditions, and other inflammatory diseases
06/03/2004US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases
06/03/2004US20040106663 Inhibitors of fungal invasion
06/03/2004US20040106661 Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors
06/03/2004US20040106657 Indolyl derivatives
06/03/2004US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
06/03/2004US20040106645 Antagonists of melanin concentrating hormone receptor
06/03/2004US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
06/03/2004US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
06/03/2004US20040106626 amidine containing compounds which inhibit serine proteases
06/03/2004US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same
06/03/2004US20040106620 5-Substituted-2-arylpyrazines
06/03/2004US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
06/03/2004US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors
06/03/2004US20040106607 New compounds
06/03/2004US20040106606 Dihydropyrones with tethered heterocycles
06/03/2004US20040106600 N-substituted piperidine derivatives as serotonin receptor agents
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040106559 for inhibiting proteases
06/03/2004US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides
06/03/2004US20040106520 A pplying to plants; controlling weeds
06/03/2004DE10254336A1 Carbonsäureamide Carboxamides
06/03/2004DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer
06/03/2004CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/03/2004CA2506112A1 Substituted aralkyl derivatives
06/03/2004CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors
06/03/2004CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases
06/03/2004CA2502700A1 Diagnostic method for celiac sprue
06/03/2004CA2502017A1 N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
06/02/2004EP1424335A1 Indole derivatives
06/02/2004EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
06/02/2004EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
06/02/2004EP1423363A1 Oral antidiabetic agents
06/02/2004EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors
06/02/2004EP1423122A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
06/02/2004EP1423120A1 2h-phthalazin-1-ones and methods for use thereof
06/02/2004EP1423112A1 A combination of quetiapine and zolmitriptan
06/02/2004EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins
06/02/2004EP1114032B1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
06/02/2004CN1501925A Methods for the preparation of biphenyl isoxazole sulfonamides
06/02/2004CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
06/02/2004CN1152031C Isoquinoline derivatives with angiogenesis inhibiting activity
06/02/2004CN1152030C Novel heterocyclic compounds
06/02/2004CN1152024C Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and use as lipase inhibitors thereof
06/02/2004CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds
06/02/2004CN1152016C 2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide
06/02/2004CN1152014C N-aryl anthranilic acid derivatives and uses thereof
06/01/2004US6743919 2-aroylimidazole compounds for treating cancer
06/01/2004US6743914 Using tertiary amine catalyst
06/01/2004US6743852 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof
06/01/2004US6743815 Estrogen receptor modulators
06/01/2004US6743811 Oxazalidinone compounds and methods of preparation and use thereof
06/01/2004US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
06/01/2004US6743805 Treating vascular proliferative disorders
06/01/2004US6743793 Dp receptor antagonist; prostaglandin d
06/01/2004US6743791 Heterocyclic inhibitors of ERK2 and uses thereof
06/01/2004US6743788 Carbamate and oxamide compounds
06/01/2004US6743755 Substituted N-aryl nitrogen-containing heterocyclic compounds
06/01/2004CA2266016C Tricyclic inhibitors of farnesyl protein transferase
05/2004
05/27/2004WO2004043954A2 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
05/27/2004WO2004043947A1 Novel pyridine derivatives, preparation method and pharmaceutical compositions containing same
05/27/2004WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/27/2004WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2004WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors
05/27/2004WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase
05/27/2004WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004WO2004043389A2 Methods of treating cancer and related methods
05/27/2004WO2004043379A2 Chemical compounds
05/27/2004WO2004043366A2 Sulfonamides
05/27/2004WO2004043349A2 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
05/27/2004WO2004043337A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
05/27/2004WO2004014881A3 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
05/27/2004WO2004013234A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/27/2004WO2004012735A3 New effector conjugates, process for their production and their pharmaceutical use
05/27/2004WO2003088908A3 Heterocyclo inhibitors of potassium channel function